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Mucosa-associated microbiota drives pathogenic
functions in IBD-derived intestinal iNKT cells
Claudia Burrello1 , Gabriella Pellegrino2,3,*, Maria Rita Giuffrè2,*, Giulia Lovati1,*, Ilaria Magagna1, Alice Bertocchi1,
Fulvia Milena Cribiu`4, Francesca Boggio4, Fiorenzo Botti3,5, Elena Trombetta6, Laura Porretti6 , Antonio Di Sabatino7,
Maurizio Vecchi2,3, Maria Rescigno1,8, Flavio Caprioli2,3, Federica Facciotti1
Inﬂammatory bowel disease (IBD) pathogenesis has been linked to
the aberrant activation of the Gut-associated lymphoid tissues
against components of the intestinal microbiota. Although the
contribution of CD4+ T helper cells to inﬂammatory processes is being
increasingly acknowledged, the functional engagement of human
invariant natural killer T (iNKT) cells is still poorly deﬁned. Here, we
evaluated the functional characteristics of intestinal iNKT cells
during IBD pathogenesis and to exploit the role of mucosa-
associated microbiota recognition in triggering iNKT cells’ pro-
inﬂammatory responses in vivo. Lamina propria iNKT cells, isolated
from surgical specimens of active ulcerative colitis and Crohn’s
disease patients and non-IBD donors, were phenotypically and
functionally analyzed ex vivo, and stable cell lines and clones were
generated for in vitro functional assays. iNKT cells expressing a pro-
inﬂammatory cytokine proﬁle were enriched in the lamina propria of
IBD patients, and their exposure to the mucosa-associated micro-
biota drives pro-inﬂammatory activation, inducing direct pathogenic
activities against the epithelial barrier integrity. These observations
suggest that iNKT cell pro-inﬂammatory functions may contribute to
the fuelling of intestinal inﬂammation in IBD patients.
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Introduction
Crohn’s disease (CD) and ulcerative colitis (UC), known as in-
ﬂammatory bowel diseases (IBDs), are chronic inﬂammatory dis-
orders of the digestive tract (Kaser et al, 2010) occurring in
genetically predisposed individuals as the result of an abnormal
immune response of gut-associated lymphoid tissues (GALT)
against components of the intestinal microbiota (Belkaid & Hand,
2014). Whereas conventional CD4+ Th cells have been shown to play
a major role in orchestrating intestinal inﬂammatory responses
(Caprioli et al, 2008), the contribution of other mucosal T cell
populations in sustaining or controlling intestinal inﬂammation is
still under investigation (Heller et al, 2002; Fuss et al, 2004; Biancheri
et al, 2014; Burrello et al, 2018b).
Among unconventional lymphocytes, CD1d-restricted T cells are a
heterogeneous population recognizing endogenous and bacterial
lipid antigens (Behar & Porcelli, 2007; Tupin et al, 2007; Facciotti et al,
2012), a feature distinguishing them from peptide-speciﬁc major
histocompatibility complex (MHC)-restricted T cells. Different sub-
sets of CD1d-restricted T cells have been identiﬁed over the years
(Engel et al, 2016), mostly differing for their TCR repertoire and their
different function in deﬁned immune responses. Type I invariant
natural killer T (iNKT) cells, widely studied inmice andmen, express a
conserved αβ T cell receptor (TCR; Vα24-Jα18/Vβ11 in humans and
Vα14-Jα18 in mice) together with NK surface receptors and
manifest both adaptive and innate/cytotoxic functional properties
(Bendelac et al, 2007). Conversely, type II NKT express diverse TCRs, react
to non-self and self-lipid antigens, including sulfatide (Marrero et al,
2015), and have been described to play critical roles in in the regulation
of immunity to pathogens and tumors and in autoimmune disorders
(Dhodapkar & Kumar, 2017).
Although both NKT cell subsets are present in the intestinal
lamina propria (LP) (Middendorp & Nieuwenhuis, 2009), their speciﬁc
role in gut mucosal immunity and regulation of intestinal in-
ﬂammation have been only partially elucidated (Biancheri et al,
2014). Whereas the pro-inﬂammatory role of type II NKT cells has
been clearly demonstrated in human UC patients (Fuss et al, 2004,
Fuss et al, 2014) and in the chemically induced oxazolone-driven
experimental colitis (Heller et al, 2002; Iyer et al, 2018), the role of type
I iNKT cells is still controversial. In fact, iNKT cells have been reported
to either contribute to experimental intestinal inﬂammation (Kim &
Chung, 2013; Burrello et al, 2018a) or protect mice from experimental
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colitis in murine models (Saubermann et al, 2000; Ueno et al, 2005).
Moreover, their functions in human IBD are still largely unexplored.
Current evidences suggest that intestinal inﬂammation in IBD is
driven by stimulation of GALT by a dysbiotic gut microbiome (Strober,
2013; Gevers et al, 2014; Shah et al, 2016). This, in turn, is favored by IBD-
associateddefects in intestinal barrier functions (Grivennikov et al, 2012;
Kamada & Nunez, 2013; Strober, 2013; Michielan & D’inca, 2015), which
promote bacterial translocation in the intestinal LP (Fava & Danese,
2011), thus favoring the aberrant activation of both innate and adaptive
mucosal immune responses. At present, however, whether similar
events contribute to confer pro-inﬂammatory functions to intestinal
iNKT cells in IBD patients has not been elucidated. In this context, it is
well known that iNKT cells become activated upon recognition of
pathogenic bacteria during infections (Tupin et al, 2007). More recently,
a reciprocal inﬂuence between iNKT cells and the commensal gut
microbiota has been demonstrated (Middendorp & Nieuwenhuis, 2009;
Wei et al, 2010; Olszak et al, 2012; Burrello et al, 2018a), and increasing
evidences support the existence ofmutualmechanisms of regulation
between the intestinal microbiota and iNKT cells (Nieuwenhuis et al,
2009). During early neonatal and postnatal stages of development,
commensal bacteria negatively shape iNKT cell repertoire through a
CXCL16-dependent gradient (Olszak et al, 2012). In addition, under
homeostatic conditions, CD1d-dependent lipid antigens isolated
from the commensal B. fragilis directly inﬂuence iNKT cell pro-
liferation and activation status (An et al, 2014).
In this study, ex vivo LP cells isolated form surgical specimens of
IBD patients and non-IBD donors were analyzed to evaluate fre-
quency and phenotype of human intestinal iNKT cells. The direct
stimulatory potential of the mucosa-associated intestinal micro-
biota, the microbial ecology most directly in contact with GALT and
which represents the ﬁrst microbial encounter of the GALT upon
epithelial barrier disruption, was additionally tested on human
iNKT cells and in murine chronic models of colitis.
Our data demonstrate that human intestinal iNKT cells are made up
by a complex population, which is phenotypically distinct between IBD
and non-IBD patients. Recognition of mucosa-associated intestinal
microbiota induces pro-inﬂammatory cytokine secretion by iNKT cells,
promoting direct pathogenic activities against the gut epithelial barrier.
Altogether, these ﬁndings shed novel light on the contribution of
human intestinal iNKT cells in IBD pathogenesis, suggesting similar
functions between iNKT cells and conventional CD4+ T cells during
intestinal inﬂammation.
Results
Intestinal iNKT cells from IBD patients express a distinct pattern
of surface molecules and secrete pro-inﬂammatory cytokines
Different T lymphocyte subsets are recruited in the intestinal LP
during the processes associated with IBD-related inﬂammation
(Kaser et al, 2010). To initially address the contribution of type I
iNKT cells in human IBD, the frequency of circulating (Fig 1A) and
intestinal iNKT cells (Fig 1B) was analyzed ex vivo from individuals
affected by both UC (n = 16) and CD (n = 24) or noninﬂammatory IBD-
unrelated intestinal pathologies in healthy donors (HDs) (n = 27)
(Table 1). LP mononuclear cells (LPMCs) were isolated from surgical
specimens of the different subgroups, and iNKT cells were iden-
tiﬁed by hCD1d:PBS57 tetramer recognition (Fig S1A), whose spec-
iﬁcity was conﬁrmed by unloaded CD1d tetramer staining (Fig S1B).
As previously observed for other tissues (Chan et al, 2013), LP
iNKT cells displayed high variability in frequency, spanning from0.1 to
10% of the total CD3+ T lymphocytes, and in absolute numbers (Fig 1C
and D). iNKT cells were slightly more abundant in the intestinal LP
than in the peripheral blood (Fig 1A–D), in accordance with the notion
that most iNKT cells do not circulate but localize preferentially within
tissues (Kim et al, 2002). iNKT cells and tetramer-negative CD3+ T cell
frequencies and absolute numbers were not substantially different
between IBD patients and non-IBD donors (Fig 1C–E).
Co-expression by LP T lymphocytes of CD4 and CD161, a tissue-
homing integrin highly expressed by gut-tropic T cells, has been
associated with pathogenic functions in IBD patients (Fuss et al,
2004; Annunziato et al, 2008). Almost 80% of intestinal iNKT cells
were CD4+ (Figs 1F and S2), and more than half co-expressed CD161
(Fig 1F and H). Likewise, tetramer-negative CD3+ T cells were mainly
CD4+, and CD161 expression analysis conﬁrmed previously pub-
lished data in CD (Annunziato et al, 2008) and UC patients (Fuss
et al, 2004, Fuss et al, 2014) (Figs 1G and I, and S2). Interestingly,
CD161+ and CD161− CD4+ iNKT cell populations were equally rep-
resented in UC patients (Figs 1H and S2), similarly to what observed
for CD4+ tetramer-negative cells (Figs 1I and S2), whereas in HDs and
CD patients, iNKT cells were mostly CD161+.
In previous studies, the expression of the CD161 marker in
conventional T helper cells from CD patients identiﬁes IL-17–
secreting T cell subset (Th17 cells) (Cosmi et al, 2008). Here, we
found that both iNKT and conventional CD4+ T cells CD161+ cells
secreted IL-17 (Figs 2 and S3 and Tables S1 and S2), and also TNF and
IFNγ, especially in CD patients (Fig 2A). CD161+ iNKT cells secrete
moderate levels of IL-13 when polyclonally restimulated ex vivo
(Figs 2A and S3), especially those derived from UC patients, but
similar ﬁndings were observed from CD161-iNKT isolated from UC
and CD patients (Fig 2A). Interestingly, ex vivo–isolated iNKT cells
constitutively secreted relevant amounts of cytokines, in particular
IL-17, IL-13, and TNF (Fig 2B), even in the absence of in vitro
restimulation, as if they were already pre-stimulated in vivo.
To note, colonic or ileal CD localization did not substantially
inﬂuence neither the frequency nor the phenotype of LP iNKT cells
(Fig S4).
Taken together, these data indicate that phenotypically distinct
subsets of iNKT cells are present in the LP of HDs and IBD patients
and that pro-inﬂammatory cytokines are secreted by these cells in
the intestinal mucosa.
Intestinal iNKT cell lines and clone generation
To study the functional behavior of human intestinal iNKT cells,
stable cell lines and clones were generated from total LPMCs
isolated from inﬂamed intestinal tissue of IBD patients (UC and CD)
or from not inﬂamed intestinal surgical specimens (HDs) (Figs 3 and
S5A and B). Their phenotype (Fig S6) and the basal cytokine proﬁle
(Fig S7) reﬂected the expression of CD4, CD161, and cytokine se-
cretion of ex vivo–isolated iNKT cells, were fully functional, and
responded both to antigen-speciﬁc (Fig 3A) and polyclonal (Fig 3B)
stimulation with pro-inﬂammatory cytokine secretion.
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More than 400 intestinal iNKT cell-independent clones were also
generated from IBD (UC and CD) patients and HDs. These clones
were characterized by different expression levels of TCR expression
evaluated as PBS57:CD1d tetramer staining intensity (Fig S5B).
Similarly to what we observed with iNKT cell lines, antigen-speciﬁc
(Fig 3C) and polyclonal stimulation (Fig 3D) induced a potent se-
cretion of pro-inﬂammatory cytokines also on iNKT cell clones (Fig
3C). Interestingly, polyclonally stimulated UC-derived clones
showed a more heterogeneous cytokine proﬁle when compared
with HDs or CD-derived ones (Fig 3D). To note, IL17 production by
iNKT cells is hardly detectable by ELISA.
Finally, to test if intestinal iNKT cells might acquire pathogenic
functions against the intestinal epithelium upon activation, iNKT
cells were polyclonally stimulated and their supernatants, con-
taining pro-inﬂammatory cytokines (Fig 4B), were applied in vitro to
polarized epithelial Caco-2monolayers (Fig 4A). Activated iNKT cells,
independently from their origin, manifested a pathogenic potential
affecting epithelial cell monolayer integrity, as demonstrated by
decrease of trans-epithelial electrical resistance (TEER) (Fig 4C).
Similarly to conventional Th17 cells (Nizzoli et al, 2018), this effect
could be inhibited upon neutralization of several T cell cytokines,
with the notable exclusion of IL-13 (Fig 4D).
Collectively, these data indicate that the functional phenotype of
intestinal iNKT cell lines and clones reﬂects that of ex vivo–isolated
intestinal iNKT cells. Hence, these lines and clones can be used as
an innovative tool to study intestinal iNKT cells in vitro and assess
their potential contribution to gut inﬂammation.
iNKT cells respond to mucosa-associated microbiota
A current hypothesis holds that aberrant activation of pathogenic
T lymphocytes in IBD patients depends on gut microbiota rec-
ognition, and it is known that gut microbes are potent stimulators
of iNKT cell responses (Tupin et al, 2007; Kamada & Nunez, 2013;
Strober, 2013). Hence, we asked whether the gut microbiota di-
rectly activates human intestinal iNKT cells leading to the pro-
inﬂammatory phenotype of iNKT cells in IBD patients.
Figure 1. LP iNKT cells express CD4 and CD161 and
secrete pro-inﬂammatory cytokines.
(A, B) Representative dot plots (A) and summary of
frequencies (B) of circulating iNKT (hCD1d:PBS57
tetramer+, plain bars) and of conventional T cells
(hCD1d:PBS57 tetramer−, dotted bars) among total CD3+
lineage cells in the peripheral blood (PB) of HDs (n = 15)
or IBD patients (n = 5). (C–E) Representative dot plots (C),
summary of frequencies (D and E, left panels), and
absolute numbers (D and E, right panels) of colonic iNKT
(D) and of conventional T cells (E) in the LP of uniﬂamed
donors (HDs, white bars, n = 27), UC patients (blue bars,
n = 16), and CD patients (red bars, n = 24). (F, G)
Representative dot plots (right panels) and cumulative
frequencies of CD4/CD161–expressing cells among iNKT
(tetramer+, F) and conventional T cells (tetramer−, G)
isolated from the LP of HDs (left panels), UC patients
(middle panels), and CD patients (right panels). (H, I)
Comparison between CD161+ and CD161− expressing
cells among CD4+ iNKT (H, tetramer+) and conventional
T cells (I, tetramer−) isolated from the LP of HDs (white
bars, n = 27), UC patients (blue bars, n = 16), and CD
patients (red bars, n = 24). Left panels, frequencies; right
panels, absolute numbers. Statistical signiﬁcance was
calculated using the Kruskal–Wallis nonparametric test
for multiple comparisons. P < 0.05 (*), P < 0.01, (**), P <
0.001 (***) were regarded as statistically signiﬁcant.
Error bars: mean ± SEM.
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To this aim, the gut mucosa-associated microbiota was collected
from surgical specimens of IBD patients and HDs, and the bacterial
composition was evaluated by 16S rRNA sequencing (Fig 5). Un-
weighted UniFrac-based comparisons of the samples isolated from
the colon of 9 HDs, 7 UC patients, and 6 colonic CD patients (Fig 5A), as
well as from the ileum of 8 HDs and 10 ileal CD patients (Fig S8) were
performed. Principal coordinates analysis (PCoA) differentiated
healthy microbiota samples from IBD patients, but no differences
between UC and CD samples were detected (Fig 5A). Also, mucosa-
associated microbiota derived from IBD patients showed a lower
α-diversity when compared with HD microbiota (Pascal et al, 2017;
Gevers et al, 2014) (Fig 5B). The taxonomic composition of the
mucosa-associated microbiome of IBD patients showed an in-
crease of Proteobacteria and Fusobacteria and a decrease in
Firmicutes compared with HDs. As previously reported (Kim &
Chung, 2013; Pascal et al, 2017), these alterations were more ev-
ident in microbiota samples from CD as compared with UC pa-
tients (Figs 5C and S8). To note, around 15% of the microbial
ecology at genus level was signiﬁcantly changed in the samples
analyzed (Fig 5D). Speciﬁc variations between colonic IBD and HD-
derived samples included the increase of Actinomyces and
Streptococcus and the decrease of Roseburia, Blautia, Desulfo-
vibrio, Odoribacter, and Lachnospinaceae ND3007 (Fig 5D and E);
speciﬁc CD-associated changes included increase of Lawsonella,
Dietzia, Ralstonia, and Enhidrobacter, whereas UC-associated
changes included increase of Erysipelotricheaceae, Ruminococca-
ceae, Ruminoclostridium, and Christanesellacee (Fig 5D and E).
To test whether the pro-inﬂammatory phenotype of
ex vivo–analyzed iNKT cells was linked to the distinguished gut
microbiota proﬁle of IBD patients, we exposed iNKT cells (lines and
clones) in vitro to the mucosa-associated microbiota samples from
IBD and HDs that we had characterized bymetagenomic analysis (Fig
6A). All the iNKT cell lines (Fig 6B) and the clones (Fig S9B anddata not
shown) cultured with monocyte-derived dendritic cells in the
presence of gut microbiota, regardless its origin, were activated and
secreted high amounts of pro-inﬂammatory cytokines such as TNF,
IFNγ, and IL-13. Nonetheless, qualitatively and quantitatively dif-
ferent responses were observed when iNKT cell lines were exposed
to the mucosal microbiota isolated from IBD patients compared with
HDs (Fig S9A, representation of experiments with one microbiota
donor per group; Fig 6B quantiﬁcation of pulled experiments with
n = 6/8 independent donors per group). These results are in line
with the overall complexity of the microbiota ecology and with
the possible presence of different TCR speciﬁcities among
iNKT cell lines (Cameron et al, 2015). Interestingly, also HD-derived
microbiota stimulated iNKT cells and induced the secretion of pro-
inﬂammatory cytokines. However, exposure of CD-derived iNKT cell
lines to IBD-derived microbiota triggered a strong production of pro-
inﬂammatory cytokines. Conversely, exposure of iNKT cell lines de-
rived from the intestinal tissue of HDs to the microbiota samples
Table 1. Patients description.
Clinical parameter Healthy controls, n = 27 UC, n = 16 CD, n = 24
Male/female, n 14/13 9/7 12/12
Age at enrolment, mean ± SD, yr 69.5 (±12.31) 40.75 (±13.3) 39.61 (±7.37)
Disease duration, mean ± SD, yr — 8.8 (±4.8) 10.5 (±6.21)
Smoking status, yes/no/ex — 2/13/1 3/19/2
CD, n
L1 ileal — — 10
L2 colonic — — 3
L3 ileocolonic — — 11
L4 upper — — 0
B1 (not strict/not penetrating) — — 6
B2 (stricturing) — — 13
B3 (penetrating) — — 5
UC, n
E1 proctitis — 1 —
E2 left-sided — 11 —
E3 pancolitis — 4 —
Concomitant therapy at enrolment
No therapy — 7 15
Antibiotics, n — 0 1
Mesalamine, n — 6 3
Thiopurines, n — — 5
Corticosteroids, n — 3 2
Anti-TNF — — 2
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(from IBD or HD) did not result in a marked pro-inﬂammatory cy-
tokine skewing. In addition, IL-17 secretion by UC iNKT cell lines was
decreased upon exposure to UC-derived microbiota (Fig 6B).
Next, we tested whether the microbiota-induced pro-
inﬂammatory effect on iNKT cells associated with APC modulation.
In vitro–differentiated monocyte-derived dendritic cells (moDC) or
ex vivo–sorted CD1d+ HLADR+ intestinal APCs (composed by mac-
rophages, dendritic cells, monocytes, as well as few granulocytes and
B cells; Fig S10) were exposed to mucosa-associated microbiota
samples, and then their capacity to induce different cytokine proﬁles
in iNKT cells was evaluated. The exposure of CD1d+ sorted intestinal
APCs, as compared with moDC, to gut microbiota induced a pref-
erential Th1/Th17 response (Caprioli et al, 2013) and a relevant IL13
production by iNKT cells, whereas only those challenged with CD-
derived microbiota induced a sustained IFNγ secretion (Fig 6C). To
note, unstimulated intestinal APCs were sufﬁcient to induce an IL17
response by iNKT cells.
In conclusion, iNKT cells become functionally activated upon
exposure to human mucosa-associated microbiota and display a
highly skewed pro-inﬂammatory phenotype.
iNKT cells recognize intestinal pathobionts by innate and
adaptive mechanisms and become pathogenic against intestinal
epithelial cells
Functional activation of iNKT cells is mediated by CD1d-dependent
and/or independent mechanisms (Bendelac et al, 2007). To explore
whether microbiota-induced iNKT cell activation requires CD1d
presentation, we exposed iNKT cells in vitro to twowell-characterized
puriﬁed intestinal pathobionts, known to be present in IBD patients
and to mediate inﬂammatory responses (Schultz et al, 2017; Palmela
et al, 2018), that is, adherent invasive Escherichia coli (AIEC) strain
LF82 (Figs 7A and B and S11A) and Salmonella typhimurium (Figs 7C
and D and S11B). Both strains induced a potent dose-dependent pro-
inﬂammatory activation of iNKT cells, resulting from a combination of
both antigenic and non-antigenic (innate) stimulation, as demon-
strated by its only partial inhibition after CD1d blockade (Figs 7A–D
and S11).
Noteworthy, in our cohort of patients, the genus Salmonella was
detected almost exclusively in mucus-associated IBD samples (Fig 7F),
whereas the Escherichia/Shighella genus was detected also at lower
levels in HD samples (Fig 7E). However, iNKT cell lines and clones of
different origin were similarly activated in vitro with all the bacteria
tested, including the laboratory E. Coli strain HB101 (data not shown).
Finally, to test if exposure to the mucosa-associated microbiota
might induce speciﬁc pathogenic functions against the intestinal
epithelium, iNKT cells were exposed to the mucosa-associated IBD-
derived microbiota (Fig 8A). Consistent to our previous ﬁndings,
microbiota-activated iNKT cells secreted pro-inﬂammatory cyto-
kines (Fig 8B).
Microbiota-activated iNKT cells, regardless of their origin,
manifested pathogenic activities affecting epithelial cell monolayer
integrity, as demonstrated by decrease of TEER (Fig 8C). In addition,
speciﬁc inhibition of iNKT cell–derived TNF and IFNγ abolished their
pathogenic functions towards epithelial cell integrity (Fig 8D).
These ﬁndings suggest that exposure to mucosa-associated
bacteria is sufﬁcient to drive both innate and adaptive iNKT cell
pro-inﬂammatory activation. Once activated, intestinal iNKT cells
Figure 2. Mucosal iNKT secrete pro-inﬂammatory
cytokines.
(A) Comparison between pro-inﬂammatory cytokines
(TNF, IFNγ, IL17A, and IL13) produced upon brief
polyclonal stimulation by CD161+ and CD161− expressing
cells among CD4+ iNKT (left panels) and conventional
T cells (right panels) isolated from the LP of HDs (white
bars, n = 27), UC patients (blue bars, n = 16), and CD
patients (red bars, n = 24). Statistical signiﬁcance was
calculated using the Kruskal–Wallis nonparametric
test for multiple comparisons. P < 0.05 (*), P < 0.01 (**)
were regarded as statistically signiﬁcant. Error bars:
mean ± SEM. (B) Frequency of pro-inﬂammatory
cytokines (TNF, IFNγ, IL17A, and IL13) produced by
unstimulated CD4+ CD161+ (left graphs) or CD4+CD161−
(right graphs) intestinal ex vivo–isolated iNKT cells
(tetramer+) fromHDs (n = 27), UC patients (n = 16), and CD
patients (n = 24). Error bars: mean ± SEM.
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secrete pro-inﬂammatory cytokines conferring pathogenic features
towards the intestinal epithelium.
iNKT cell become functionally pro-inﬂammatory upon exposure
to intestinal microbiota during intestinal inﬂammation in vivo
Finally, we aimed at recapitulating in vivo the effects of bacteria
exposure on pro-inﬂammatory activation of iNKT cells during
intestinal inﬂammation. To this aim, chronic experimental in-
testinal inﬂammation was induced in mice by repetitive dextran
sodium sulphate (DSS) administration in the presence or ab-
sence of broad-spectrum antibiotics (Figs 9A and S12). This
treatment depleted the community of intestinal live bacteria, as
demonstrated by fecal plating and CFU counting (data not
shown). Epithelial barrier damage (Fig 9B) and signs of in-
ﬂammation, including weight loss, colon shortening, and colonic
Figure 3. Human intestinal iNKT cell line and clones generation.
(A) TNF, IFNγ, and IL-13 secretion upon co-culture of iNKT cell lines with moDC in the absence (white bars) or presence (dark grey bars) of aGalcer and of
concomitant CD1d blocking (light grey bars). (B) Cytokine measurement in the supernatants of iNKT cell lines polyclonally stimulated (PMA/ionomycin, 3 h in the absence
of Brefeldin A). (C) TNF, IFNγ, and IL-13 production by representative iNKT cell clones (HD, n = 4; CD, n = 7; UC, n = 6) upon αGalCer stimulation in the presence (light grey bars)
or absence (dark grey bars) of anti hCD1d-blocking antibodies. White bars, medium only. (D) Cumulative FACS analysis of the cytokine proﬁle of 10 HD (out of 12),
50 UC (out of 196), and 50 CD (out of 210) intestinal-derived iNKT cell clones upon 3 h PMA/ionomycin stimulation (in the presence of Brefeldin A). Statistical signiﬁcance
was calculated using the Kruskal–Wallis nonparametric test for multiple comparisons. P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) were regarded as statistically
signiﬁcant. Error bars: mean ± SEM.
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expression of pro-inﬂammatory cytokines (Fig S12A–C), were strongly
reduced by antibiotic administration (Hernandez-Chirlaque et al,
2016). Importantly, the antibiotic treatment greatly reduced the
bacterial translocation (Fig 9C). In these mice, colonic expres-
sion levels of CXCL16, the chemokine responsible for iNKT cell
chemoattraction into the gut (Geissmann et al, 2005; Olszak et al,
2014; Burrello et al, 2018a), and of its receptor CXCR6 were
strongly diminished (Fig 9D). Consistent with these observations,
iNKT and CD4+ T cell frequencies (Fig 9E) and absolute numbers
(Fig 9F) were decreased both in the colon and in the mesenteric
LN (Fig S12D and E) of mice treated with DSS in the presence of
antibiotics.
Most importantly, the reduction of intestinal bacterial trans-
location into the LP during intestinal inﬂammation signiﬁcantly
inhibited proliferation and CD69 up-regulation (Fig 9G), as well as
pro-inﬂammatory cytokines secretion (Fig 9H) by both colonic (Fig
9G andH) andmesenteric LN-derived (Fig S12F and G) iNKT and CD4+
T cells.
In conclusion, these data collectively indicate that exposure to
the intestinal microbiota is required for iNKT cell pro-inﬂammatory
activation in the colonic mucosa and that iNKT and CD4+ T cells
manifest in vivo similar pro-inﬂammatory activities during intes-
tinal inﬂammation.
Discussion
A functional involvement of iNKT cells has been suggested for a wide
variety of human autoimmune disorders, includingmultiple sclerosis
(Illes et al, 2000), rheumatic diseases (Van Der Vliet et al, 2001), and
asthma (Akbari et al, 2006). Conversely, iNKT cell contribution to IBD
pathogenesis is still incompletely understood. By studying human
intestinal tissues, we showed that intestinal iNKT cells isolated from
IBD patients possess a pro-inﬂammatory phenotype similar to that
of conventional CD4+ T cells and manifest pathogenic features
upon exposure to intestinal mucosa-associated microbiota.
Thus, to our knowledge, this is the ﬁrst comprehensive report of
human intestinal iNKT cells in IBD patients.
Technical difﬁculties hampered for long time univocal attribu-
tion of iNKT cell pathogenic or protective roles in human diseases.
Before the advent of the tetramer technology, (i) NKT cells could be
identiﬁed either by the expression of NK-related markers (CD56
and/or CD161, the human counterpart of the murine NK1.1) together
with CD3, by the reaction to CD1d stimulation, or by Vα24 TCR
expression (Dellabona et al, 1994). It is believed, therefore, that old
studies on iNKT cell functions most likely included different
subsets, such as CD1d-restricted type 2 NKT, mucosal associated
invariant T cells (MAIT), and γδ T cells (Mori et al, 2016). In addition,
Figure 4. Human iNKT cells are pathogenic against epithelial cells.
(A) Schematic representation of the experiment. (B) Multiplex analysis of TNF, IFNγ, IL-17A, and IL-13 concentrations in the supernatants of polyclonally stimulated
iNKT cells. (C) TEER measured upon co-culture of Caco-2 cells with supernatants of unstimulated (open circles) or polyclonally stimulated (closed circles) iNKT cells. Left
panel, representative plot; right panel, area under the curve (AUC) of n = 5 independent experiments with iNKT lines. (D) TEER measured upon co-culture of Caco-2 cells
with supernatants of unstimulated (open circles) or polyclonally stimulated iNKT cell lines in the absence (closed circles) or presence of anti IFNγ/TNF (red circles), anti
TNF (blue circles), anti IL17 (purple circles), anti IFNγ (green circles), and anti IL13 (orange circles) inhibitors. Left panel, representative plot; right panel, AUC of n = 3
independent experiments. Statistical signiﬁcance was calculated using the Kruskal–Wallis nonparametric test for multiple comparisons. P < 0.05 (*), P < 0.01 (**), P < 0.001
(***) were regarded as statistically signiﬁcant. Error bars: mean ± SEM.
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peripheral blood (PB) and tissue iNKT cell frequency is greatly
variable among individuals (Chan et al, 2013). The analysis of the
LPMC isolated from IBD patients and non-IBD donors conﬁrmed
this relevant intra-individual variability also for intestinal iNKT cell
frequencies, which did not correlate with any epidemiologic or
clinical parameters, including age, sex, concomitant therapy, dis-
ease localization, and duration.
Functionally different subsets of iNKT cells can be distinguished
according to the expression of CD4 (Chan et al, 2013), whose
engagement by CD1d molecules potentiates iNKT cell activation
(Tonti et al, 2009). Human and murine tissue–derived iNKT cells are
mostly CD4+ (Matsuda et al, 2008), and we here observed that up to
80% of human intestinal tetramer+ iNKT cells express CD4 both in
HDs and IBD patients. CD161 expression, instead, has been spe-
ciﬁcally associated to intestinal tissue distribution of several T cell
subsets, including MAIT cells and TCR γδ cells (Fergusson et al, 2011).
In our study, LP iNKT cells from IBD patients and HDs mainly co-
expressed CD4 and CD161 and secreted substantial amounts of
Figure 5. Mucosa-associated microbiota analysis in IBD patients and HDs.
(A) Microbiome clustering based on unweighted principal coordinate analysis (PCoA) UniFrac metrics of mucosa-associated microbiota derived from HDs (orange
triangles), UC patients (blue dots), and colon CD (red squares) patients. (B) Rarefaction curves and cumulative AUC showing microbial richness based on the Chao1 index.
(C) Bar plots of the taxonomic composition showing relative abundances >1% of bacterial phyla. (D) Relative abundance of OTUs differentially present in the mucosa-
associated microbiota derived from HDs (blue dots), UC patients (green dots), and CD patients (red dots) compared with the other groups. (E) Comparison of the relative
abundances of different taxa between colon CD patients (left panels) or UC patients (right panels) and HDs. Blue bars, taxa enriched in HD; red bars, taxa enriched in IBD
patients. Statistical signiﬁcant differences were assessed through the Mann–Whitney test for comparisons between two groups or with the Kruskal Wallis test with least
signiﬁcant difference post hoc test for more than two groups. *P < 0.05, **P < 0.01. Error bars: mean ± SEM.
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pro-inﬂammatory cytokines. These data are in accordance with
previous reports indicating that CD4+ CD161+ intestinal T cell subsets
might exert speciﬁc pathogenic functions, both in CD (Cosmi et al,
2008) and UC patients (Fuss et al, 2004). Those reports, though,
either excluded iNKT cells from the analysis (Cosmi et al, 2008) or
focused on type II sulfatide-speciﬁc NKT subsets (Fuss et al, 2004;
Fuss et al, 2014).
Here, we also report that both in mice and men, pro-
inﬂammatory cytokine secretion is a key functional attribute of
intestinal iNKT cells, leading to pathogenic activities against the
intestinal epithelium.
Distinct Th subsets in the gut are known to secrete speciﬁc Th1 or
Th2 cytokines, although context-dependent functional plasticity
has been demonstrated for murine and human intestinal Th
subsets (Huber et al, 2017). Similarly to murine (Lee et al, 2015) and
PB-derived cells (Snyder-Cappione et al, 2010), in our analyses,
intestinal iNKT cells possess an intrinsic capability to secrete a
broad array of Th1, Th2, and Th17 cytokines. This characteristic,
shared with other innate populations, could be an evolutionary
conserved functional requirement for cells endowed with mucosal
surfaces patrolling roles (Bamias et al, 2014). Indeed, similarly to
other unconventional T cell subsets (Dunon et al, 1997), iNKT cells
colonize mucosal tissues very early during ontogeny (Nieuwenhuis
et al, 2009) as a consequence of an elevated epithelial expression of
CXCL16 (Olszak et al, 2012).
Healthy and IBD-derived mucosa-associated microbiota were
capable to efﬁciently activate in vitro human intestinal iNKT cells,
stimulate cytokine secretion, and induce pathogenic functions.
Several evidences suggest a reciprocal inﬂuence of iNKT cells and
the intestinal gut microbiota (Nieuwenhuis et al, 2009; Wingender
Figure 6. iNKT cells react to mucosa-associated microbiota.
(A) Schematic representation of the experiment. (B) Cytokine proﬁle of iNKT cell lines (HD, UC, and CD) co-cultured 36 h with monocyte-derived dendritic cells
exposed to 100 ng of mucosa-associatedmicrobiota isolated from 8 HDs (blue dots), 7 UC patients (green dots), and 8 CD patients (red dots). (C) Frequency of TNF, IFNγ, IL17,
and IL13 positive iNKT cells co-cultured 36 h withmoDC or ex vivo–sorted CD1d+MHCII+CD3− intestinal APCs in the absence (white dots) or presence of aGalCer (grey dots) or
to 100 ng of mucosa-associated microbiota isolated from at least 6 HDs (blue dots), 4 UC patients (green dots), and 6 CD patients (red dots) in three independent
experiments. Statistical signiﬁcance was calculated using the Kruskal–Wallis nonparametric test for multiple comparisons. P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) were
regarded as statistically signiﬁcant. Error bars: mean ± SEM.
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et al, 2012; Burrello et al, 2018b). iNKT cells affect murine gut col-
onization by commensal microorganisms (Nieuwenhuis et al, 2009),
whereas during early neonatal and postnatal stages of develop-
ment, commensal bacteria negatively shape iNKT cell repertoire
(Olszak et al, 2012). The commensal B. fragilis, known to produce
lipid antigens controlling homeostatic iNKT cell proliferation and
activation (An et al, 2014), was detected only in two HDs and three
colon CD-derived samples. Further studies are required to un-
derstand if reduction of B. fragilis in IBD patients might correlate
with pro-inﬂammatory functional skewing of human intestinal
iNKT cells.
IBD patients harbor signiﬁcant variations in the intestinal
microbiota composition as compared with non-IBD controls (Kaser
et al, 2010), deﬁned by an overall decrease of α-diversity and also by
alterations of microbial taxa relative abundances, that is, speciﬁc
increase in Proteobacteria (such as adherent-invasive E. coli and
Enterobacteriaceae in CD) and decrease in Firmicutes (such as F.
prausnizii) (Gevers et al, 2014). These variations were conﬁrmed in
our samples, including the decrease in the butyrate-producing
Roseburia (Machiels et al, 2014), Blautia (Takahashi et al, 2016),
and Odoribacter (Morgan et al, 2012) in IBD versus HDs, as well
as the increase of Erysipelotricheaceae in UC patients (Pascal
et al, 2017).
From a mechanistic point of view, our data suggest that the loss
of the barrier integrity might be the critical event exposing
iNKT cells to the mucosa-associated microbial ecology. Once in
contact to the microbiota, as we showed, intestinal iNKT cells
could be activated through TCR-dependent and TCR-independent
mechanisms (Brigl et al, 2003), fuelling intestinal inﬂammation
and contributing to propagate pathogenic activities towards the
intestinal epithelium. Increased epithelial barrier permeability is
considered a crucial event for IBD development, as a “leaky gut” is
deemed responsible for the breakdown of intestinal tolerance
through an increased translocation of bacterial and luminal an-
tigens (Michielan & D’inca, 2015). Primary defects in epithelial junc-
tional proteins, as JAM-A, are sufﬁcient to increase translocation of
bacteria in the LP (Laukoetter et al, 2007).
So far, few bacteria-derived glycoshphingolipid antigens capable
to speciﬁcally activate iNKT cells have been identiﬁed, including
those isolated from the cell wall of Gram-negative Sphingomonas
spp., Borrelia burgdoferi, and Mycobacteria (Fischer et al, 2004;
Kinjo et al, 2005; Mattner et al, 2005; Sriram et al, 2005; Kinjo et al,
2006). Conversely, no iNKT-speciﬁc lipid antigens have been isolated
from adherent invasive E. coli and Salmonella, two well-known
intestinal pathobionts consistently present in our IBD- and non-
IBD–derived samples and which efﬁciently stimulated iNKT cell
responses partially through CD1d-dependent mechanisms. Abun-
dant evidences instead exist that iNKT cells can be activated in an
innate fashion by microbial products such as LPS (Brigl et al, 2003;
Mattner et al, 2005), either directly through TLR4 binding (Askenase
et al, 2005) or after IL-12/IL-18–mediated activation of LPS-stimulated
dendritic cells (Nagarajan& Kronenberg, 2007). Our data suggest that
in addition to an innate microbiota-dependent iNKT cell activation,
endogenous lipid antigens might be induced or up-regulated in
bacteria-stimulated moDC, thus explaining the observed antigen-
speciﬁc activation by iNKT cells.
Upon exposure to the commensal intestinal microbiota, acti-
vated intestinal iNKT cells secreted a broad array of cytokines,
including TNF and IFNγ, which are known to increase intestinal
permeability (Vercammen et al, 2008), and those were directly
Figure 7. Human iNKT cells respond to stimulation with pathogenic intestinal bacterial strains.
(A, C) IFNγ (left panels), TNF (middle panels), and IL-13 (right panels) in the supernatants of iNKT cells co-cultured 36 h with monocyte-derived dendritic cells
exposed to increased doses of the adherent-invasive E. coli LF82 (AIEC, A) and of Salmonella typhimurium (C). Light grey bars, stimulation in the presence of anti-CD1d
blocking antibody. (B, D–F) Cumulative representation of IFNg production upon exposure to AIEC (B) or Salmonella typhimurium (D) in at least three independent
experiments with two different HD clones, three different CD clones, and three different UC clones (E, F). Escherichia/Shigella (E) and Salmonella (F) genus in colonic HDs
(n = 9), UC (n = 7), colonic CD (n = 6), ileal HD (n = 7), and ileal CD (n = 7). Statistical signiﬁcance was calculated using the Kruskal–Wallis nonparametric test for
multiple comparisons. P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) were regarded as statistically signiﬁcant. Error bars: mean ± SEM.
Pro-inﬂammatory role of iNKT cells in IBD Burrello et al. https://doi.org/10.26508/lsa.201800229 vol 2 | no 1 | e201800229 10 of 17
responsible for in vitro iNKT cell pathogenic functions. We recently
demonstrated that human Th17 cells isolated from the ileum of CD
patients co-secrete pro-inﬂammatory IFNγ and TNF conferring
pathogenic properties against the intestinal epithelium (Nizzoli
et al, 2018), suggesting that during intestinal inﬂammation,
iNKT cells and conventional CD4+ T cells might manifest a similar
behavior.
Differently to conventional Th cells, though, iNKT cells can also
behave as innate cells that, upon loss of barrier integrity, rapidly
and massively respond to the commensal microbiota trans-
location into the LP. Abolishment of bacterial translocation by
broad-spectrum antibiotic treatment during experimental chronic
colitis efﬁciently blocked iNKT (and conventional CD4+ T cells)
activation and cytokine secretion, recapitulating in vivo what
observed in vitro and providing a rationale for possible targeted
interventions aimed at containing immune cell responses in IBD
patients.
In conclusion, our study sheds novel light on the pathogenic
functions of iNKT cells during intestinal inﬂammation in IBD pa-
tients. Moreover, it suggests that a wider knowledge of the human
microbiome at the community level, rather than on single microbial
species, can better contribute to the ﬁnal understanding of the
microbiota role during human pathologies. Finally, this work in-
dicates that during intestinal inﬂammation, iNKT cells share similar
pro-inﬂammatory functions to conventional T cells, thus contrib-
uting to the fuelling of inﬂammatory processes.
Materials and Methods
Human subjects
Buffy-coated blood (HD, n = 15; IBD, n = 5) and intestinal specimens
of UC patients (n = 16), CD patients (n = 24), and patients undergoing
intestinal surgical resection for pathologies unrelated to IBD, in-
cluding diverticular disease and intestinal tumors (n = 27) were
obtained from the IRCCS Policlinico Ospedale Maggiore, Milan, Italy.
The clinical characteristics and concomitant therapies of IBD pa-
tients are summarized in Table 1.
Cells isolation
Human PBMCs were isolated by Ficoll-Hypaque gradient (Sigma-
Aldrich). Human LPMCs were isolated as previously described
(Caprioli et al, 2008). Brieﬂy, the dissected intestinal mucosa was
freed of mucus and epithelial cells in sequential steps with DTT (0.1
mmol/l) and EDTA (1 mmol/l) (both from Sigma-Aldrich) and then
Figure 8. Microbiota-stimulated human iNKT cells are pathogenic against epithelial cells.
(A) Schematic representation of the experiment. (B) Multiplex analysis of TNF, IFNγ, IL-17A, and IL-13 concentrations in the supernatants of iNKT cells co-cultured with
moDC alone (open circles) or with moDC stimulated with intestinal microbiota (closed circles). (C) TEER measured upon co-culture of Caco-2 cells with supernatants
of iNKT cells co-cultured with moDC alone (open circles) or with moDC stimulated with intestinal microbiota (closed circles). Left panel, representative plot; right
panel, area under the curve (AUC) of n = 4 independent experiments with iNKT cell lines. (D) TEER measured upon co-culture of Caco-2 cells with supernatants of iNKT cells
with moDC alone (open circles) or with moDC stimulated with intestinal microbiota (closed circles) in the absence (closed circles) or presence of anti IFNγ/TNF
(grey circles) inhibitors. Left panel, representative plot; right panel, AUC of n = 3 independent experiments. Statistical signiﬁcance was calculated using the Kruskal–Wallis
nonparametric test for multiple comparisons. P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) were regarded as statistically signiﬁcant. Error bars: mean ± SEM.
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Figure 9. Intestinal microbiota elimination reduces pro-inﬂammatory activation of iNKT cells during experimental chronic colitis.
(A) Schematic representation of the treatments. (B) H&E staining (scale bar: 100 μm) and cumulative histological score of colon specimens obtained from untreated
(white bars), ABX-treated (light grey bars) DSS-treated (black bars), and DSS + ABX–treated (dark grey bars) mice. (C) Fluorescence microscopy of bacterial DNA
after FISH with Eubacteria probes (Eub-488) in untreated, ABX-treated, DSS-treated, and DSS + ABX–treated mice as indicated. DAPI, staining of nuclei. (D) Colonic
expression levels of cxcl16 and cxcr6 in mice untreated (white bars), ABX-treated (light grey bars), treated with DSS (black bars), or with DSS + ABX (dark grey bars).
(E) Representative dot plots (left), frequency (right), and (F) absolute numbers of colonic iNKT cells and CD4+ T cells in mice untreated (white bars), ABX-treated (light grey
bars), treated with DSS (black bars), or with DSS + ABX (dark grey bars). (G) Absolute number of ki67 and CD69 colonic iNKT cells (upper panels) and CD4+ T cells
(lower panels) and (H) percentage of TNF-, IFNγ-, and IL17-producing iNKT cells (left panels) and CD4+ T cells (right panels) inmice untreated (white bars), ABX-treated (light
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digested with collagenase D (400 U/ml) (Worthington Biochemical
Corporation) for 5 h at 37°C. LPMCs were then separated with a
Percoll gradient and cultured in complete RPMI 1640 medium
containing 5% human serum (Sigma-Aldrich) and 100 U/ml IL-2
(Proleukin).
Intestinal iNKT cell line and clone generation
Human iNKT cell lines were generated from sorted CD45+CD3+ CD1d:
PBS57Tet+ cells isolated from total LPMCs or PBMCs.
Sorted iNKT cells were expanded in vitro for 2 wk in the presence
of irradiated peripheral blood feeders, hIL2 (100 U/ml; Proleukin)
and PHA (1 μg/ml; Sigma-Aldrich).
iNKT cell clones were generated via cloning by limiting dilution
according to the protocol described in Libero (2009) and re-
stimulated with irradiated feeder cells, PHA (1 μg/ml; Sigma-
Aldrich) and hIL-2 (100 U/ml; Proleukin) every 21 d.
iNKT-cell in vitro stimulation
In vitro polycolonal iNKT cell stimulation was performed with 0.1 μM
PMA and 1 μg/ml ionomycin (Sigma-Aldrich) for 3 h. Neutralizing
antibodies to CD1d (BD) were used at the concentration of 10 μg/ml.
For antigen-speciﬁc stimulation, 5 × 104 antigen-presenting cells
(moDC or CD45+HLA-DR+ intestinal LPMCs) were plated in each well
in 1:1 ratio with human iNKT cells. Sonicated αGalCer was used at
40 ng/ml.
For bacteria stimulation assays, puriﬁed bacterial strains (AIEC
LF82 and S. typhimurium) underwent cycles of heat inactivation and
freezing/thawing before being serially diluted, starting from 5 × 106
CFU/well (100:1 bacteria:APC) to 5 × 105/well (1:1 bacteria:APC). The
isolates of patient mucosa-associated microbiota were normalized
according to their protein content (Pierce BCA Protein Assay kit;
Thermo Fisher Scientiﬁc). After 36 h, T cell activation was estimated
by measuring cytokine released in culture supernatants by ELISA
assays, cytometric bead array (BD) or intracellular staining.
Flow cytometry
Human andmurine cells were stained with combinations of directly
conjugated antibodies as speciﬁed in Table S3, all sourced from BD,
eBioscience, or BioLegend. The gating strategy to identify human
iNKT cells is described in Fig S1.
Intracellular cytokines were detected after stimulation of human
cells (iNKT cells and conventional T cells) for 3 h with 0.1 μM PMA
and 1 μg/ml ionomycin (Sigma-Aldrich). 10 μg/ml Brefeldin A
(Sigma-Aldrich) was added for the last hour of stimulation. The cells
were ﬁxed and permeabilized with Cytoﬁx/Cytoperm (BD) before
the addition of the antibodies, detecting the cytokine released.
Multiplexing analysis of cytokines in supernatants collected after
in vitro stimulation was performed with a cytometric bead array
assay, according to the manufacturer’s protocol (BD).
The samples were analyzed by a FACSCanto ﬂow cytometer (BD),
gated to exclude nonviable cells on the basis of light scatter. Data
were analyzed using FlowJo software (Tristar).
Microbiota identiﬁcation by 16S rRNA gene ampliﬁcation,
sequencing, and data analysis
Faeces and mucus scraped from the colon were stored at −80°C
until the DNA was extracted with GNOME DNA Isolation Kit (MP)
following the protocol described in the study by Furet et al (2009).
Partial 16S rRNA gene sequences were ampliﬁed using primer pair
Probio_Uni and /Probio_Rev, targeting the V3 region of the 16S rRNA
gene sequence (Milani et al, 2013b). 16S rRNA gene sequencing was
performed using a MiSeq (Illumina) at the DNA sequencing facility
of GenProbio srl (www.genprobio.com) according to the protocol
previously reported (Milani et al, 2013a). Following sequencing, the
obtained individual sequence reads were ﬁltered by the Illumina
software to remove low-quality and polyclonal sequences. All
Illumina quality-approved, trimmed, and ﬁltered data were
exported as .fastq ﬁles. The .fastq ﬁles were processed using a
custom script based on the QIIME software suite (Caporaso et al,
2010). Quality control retained sequences with a length between
140 and 400 bp and mean sequence quality score >20, whereas
sequences with homopolymers >7 bp and mismatched primers
were omitted. To calculate downstream diversity measures (α and β
diversity indices, Unifrac analysis), 16S rRNA operational taxonomic
units (OTUs) were deﬁned at ≥99% sequence homology using uclust
(Edgar, 2010) and OTUs with less than 10 sequences were ﬁltered. All
reads were classiﬁed to the lowest possible taxonomic rank using
QIIME (Caporaso et al, 2010) and a reference dataset from the SILVA
database. Biodiversity of the samples (α diversity) were calculated
with Chao1 and Shannon indices. Similarities between samples (β
diversity) were calculated by unweighted uniFrac (Lozupone &
Knight, 2005). The range of similarities is calculated between the
values 0 and 1. PCoA representations of β diversity were performed
using QIIME (Caporaso et al, 2010).
Measurement of TEER
The Caco-2 cells were sourced from the American Type Culture
Collection and cultured in DMEM supplemented with 20% FCS, 2 mM
L-glutamine, 1 mM sodium pyruvate, 0.1 mM nonessential amino
acids and penicillin/streptomycin. The cells were split three times a
week. For TEER measurement, the cells at passage 10–30 were plated
at 15 × 103 cells/well on polyester permeable Transwell-Clear inserts
(6.5-mm diameter, 0.4-mm pore size; Corning) and grown for 5−7 d,
until ΔTEER >300 Ω*cm2 (Millicell-ERS Volt-Ohm Meter; Millipore).
The supernatants collected from intestinal CD4+ T cell clones,
stimulated for 3 h with PMA/ionomycin in Caco-2 medium, in the
presence or absence of neutralizing Ab (anti-human -IFNγ, -IL-17A,
-TNF [eBioscience], -IL13 [BioLegend] at a concentration of 20 μg/ml
for anti-IFNγ and 10 μg/ml for the others) were applied in the lower
Transwell chamber.
grey bars), treated with DSS (black bars), or with DSS + ABX (dark grey bars). N = 4/5 group in two independent experiments. Statistical signiﬁcance was calculated
using the Kruskal–Wallis nonparametric test for multiple comparisons. P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) were regarded as statistically signiﬁcant. Error bars:
mean ± SEM.
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Measurements were carried out every 30 min in the ﬁrst 2 h, then
at 24 and 48 h after stimulation. The ohmic resistance of a blank
(culture insert without cells) was measured in parallel. To obtain
the sample resistance, the blank value was subtracted from the
total resistance of the sample. The ﬁnal unit area resistance
(Ω*cm2) was calculated bymultiplying the sample resistance by the
effective area of the membrane. For comparison among treatments
with different clones, TEER was normalized to the supernatant of
each unstimulated clone.
Mice and induction of murine experimental intestinal
inﬂammation
C57BL/6 mice (Charles River, IT) of 8–10 wk of age were housed at
the European Institute of Oncology (IEO) animal facility in SPF
conditions. Littermates of the same sex and age were randomly
assigned to the different experimental groups.
For the induction of DSS-induced chronic colitis, the mice were
given 2% (wt/vol) DSS (MW 40 kD; TdB Consultancy) in their drinking
water for 7 d followed by 2 d of recovery.
To eliminate the gut microﬂora, the mice were administered
with a mix of neomycin (1g/l), ampicillin (1g/l), vancomycin
(0.5 g/l), and metronidazole (1g/l) in their drinking water throughout
the DSS treatment as described above. The weight curve was
determined by weighing the mice daily. At euthanization, the
colons were collected, their length was measured and divided in
portions to be ﬁxed in 10% formalin for histological analyses,
and they were snap-frozen for RNA extraction and for LPMC
immunophenotyping.
Histological analysis
Tissue processing was performed with a LEICA PELORIS processor
before parafﬁn embedding. Murine samples were included using an
automated system (SAKURA Tissue-Tek) as previously described
(Nizzoli et al, 2018). After hematoxylin and eosin staining, snapshots
of histology were taken using an Aperio CS2 microscope with a
scanning resolution of 50,000 pixels per inch (0.5 μm per pixel with
10× objective and 2.5 μm per pixel when scanning at 4×). Scoring of
disease activity was performed according to the criteria described
in Table S4.
FISH
Formalin-ﬁxed parafﬁn-embedded tissues were sectioned to 5 μm
thickness. The probes (EUB1, EUB2, and EUB3) used were designed
to speciﬁcally target different regions of the 16S rRNA. All the probes
were manufactured by Sigma-Aldrich and labelled with Alexa488.
Probes were applied to slides at a concentration of 5 ng/μl in
prewarmed hybridization buffer (0.9 M NaCl, 20 mM Tris, pH 7.4,
and 0.01% SDS). The slides were incubated overnight at 50°C in a
humid chamber and washed at 50°C in pre-warmed washing
buffer (0.9 M NaCl and 20 mM Tris, pH 7.4). The slides were
counterstained with DAPI. Confocal images were acquired through
HCX PL APO 40X (NA 1.25) oil immersion objective. The probes
sequences are listed in Table S5.
RNA isolation, cDNA synthesis, quantitative PCR, and gene
expression
Total RNA from intestinal tissues was isolated using TRIZOL and
Quick-RNA MiniPrep (ZymoResearch) according to the manufac-
turer’s speciﬁcations and following the MetaHIT project guidelines.
cDNAs were generated from 1 μg of total RNA with reverse tran-
scription kit (Promega). Gene expression levels were evaluated by
qPCR and normalized to RpL32 gene expression. The primer se-
quences are listed in Table S6.
Murine cell isolation
Peyer’s Patches were removed, and colonic LPMCs were isolated via
incubation with 5 mM EDTA at 37°C for 30 min, followed by further
digestion with collagenase IV and DNase at 37°C for 1 h. The cells
were then separated with a Percoll gradient. In some experiments
after isolation, the cells were re-stimulated in vitro for 3 h with
PMA/ionomycin in the presence of Brefeldin A for cytokine
secretion.
Statistics
Statistical signiﬁcance was calculated using a Wilcoxon matched-
pairs signed-rank t test not parametric and not assuming Gaussian
distribution. P < 0.05 (*), P < 0.005 (**), and P < 0.0005 (***) were
regarded as statistically signiﬁcant.
Study approval
The Institutional Review Board approved the study (permission ref.
no. EA1/107/10), and informed consent was obtained from the
subjects involved in the study. Animal procedures were approved
by Italy’s Ministry of Health (Authorizations no. 127/15, 27/13, 913/16,
415/17).
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800229.
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